Australian biomarkers could lead to Alzheimer's blood test; BRAF mutation tags drug-sensitive melanoma;

> A panel of biomarkers from Australian research could lead to a blood test for Alzheimer's disease. Article | Article

> BRAF mutation tags melanomas sensitive to MEK inhibitor drugs. Press release | Abstract

> DiaGenic has reported 82% accuracy for its ADtect biomarker blood test for diagnosis of Alzheimer's disease. Press release

> DNA promoter methylation has potential as a diagnostic and therapeutic biomarker in gallbladder cancer. Abstract

> Knee injuries are linked with cartilage health biomarkers Article

> Population-based study picks out a risk-stratification biomarker panel for Barrett's esophagus, which may lead to cancer. Abstract

And Finally… IntegraGen has scored $2.4 million in funding to support development of its biomarker-based diagnostics. Article | Press release

Suggested Articles

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.